DNA Testing 2.0: The Near Future of Population Genomics
Apr 25, 2019
CTO of the UCSC Genomics Institute
Consumer DNA testing kits were the best-selling non-Amazon branded product on Cyber Monday for the second year in row with Ancestry having sold more than 14 million DNA kits worldwide. Now clinical grade tests are starting down the same path within managed health care as well as direct to consumer. In his talk with Samsung Forum, Rob Curries goes over the basics of genetics, what these tests do and how emerging technologies such as nanopore sequencing, epigenetics and graph genomic references are poised to power DNA testing 2.0.
About the Speaker
Rob Currie is CTO of the UCSC Genomics Institute where he is responsible for technical strategy, infrastructure and industry partnerships as well as a member of the Treehouse (Pediatric Precision Medicine), BRCA Exchange (Hereditary Cancer), Braingeneers (Neuroscience) and Applied Artificial Intelligence research groups. Rob has 25 years of experience as a senior executive at Silicon Valley early stage technology companies including Universal Audio, Dash Navigation/Blackberry, Strangeberry/TiVo, Marimba/BMC and Digidesign/Avid in fields including machine learning, signal processing, distributed systems management and geospatial navigation. Rob received a BS in EECS from UC Berkeley with honors and an MBA from University of Chicago Booth with high honors.
Be the first.
At Samsung, we are passionate about fostering innovation and we'd love to keep in touch with you about the latest updates in artificial intelligence, mobility, digital health, and more. You may unsubscribe at any time.
Thank you for signing up.